EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review

Mohammad Aljumaa, Hasan Hamam Refai, Yogesh Chawla iD, Wilson I Gonsalves iD

Blood and Lymphatic Cancer: Targets and Therapy · 2026-04 · Volume 16 · 1-7

DOI: 10.2147/blctt.s586948 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2026-04. Verfasst von Mohammad Aljumaa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Mayo Clinic, Rochester, MN, USA. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

high-risk diseasemultiple myelomaoutcomes

Autor:innen und Institutionen

  • Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.

ORCID-Profile: Yogesh Chawla, Wilson I Gonsalves

Zitieren

APA

Aljumaa, M., Hamam Refai, H., Chawla, Y., & Gonsalves, W. I. (2026). Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review. Blood and Lymphatic Cancer: Targets and Therapy, Volume 16, 1-7. https://doi.org/10.2147/blctt.s586948

Vancouver

Aljumaa M, Hamam Refai H, Chawla Y, Gonsalves WI. Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review. Blood and Lymphatic Cancer: Targets and Therapy. 2026;Volume 16:1-7. doi:10.2147/blctt.s586948

BibTeX
@article{Aljumaa2026,
  author = {Aljumaa, Mohammad and Hamam Refai, Hasan and Chawla, Yogesh and Gonsalves, Wilson I},
  title = {Defining High-Risk Disease Biology in Multiple Myeloma: A Narrative Review},
  journal = {Blood and Lymphatic Cancer: Targets and Therapy},
  year = {2026},
  volume = {Volume 16},
  pages = {1--7},
  doi = {10.2147/blctt.s586948}
}
Kostenlos starten →